A Phase 1 Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ANS014004 as a Single Agent in Participants With Locally Advanced or Metastatic Solid Tumors
This early-stage clinical trial is testing a new investigational medication called ANS014004. Researchers want to see how safe it is, how it affects the body, and if it can help shrink solid tumors that have spread.
Adults aged 18 and older with solid tumor cancers that are locally advanced or have spread may be eligible. Participants must be generally active, have stable organ function, and meet specific health criteria without certain active infections or heart conditions.
Participants will receive the study medication while doctors closely monitor their safety, side effects, and how well the treatment works against their tumor through regular check-ups and scans.
This study is currently recruiting participants at multiple medical centers in the United States, including locations in California, Colorado, and Florida.
- 1Testing a new investigational medication called ANS014004 for solid tumors
- 2Open to adults aged 18 and older who meet specific health and activity requirements
- 3Currently recruiting patients at study sites in California, Colorado, and Florida
Related links
Outside pages about this study, checked by our team
This summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.